| 中文名 | 2-(丁基氨基)-4-[(反式-4-羟基环己基)氨基]-N-[[4-(1H-咪唑-1-基)苯基]甲基]-5-嘧啶甲酰胺 |
|---|---|
| 英文名 | 5-Pyrimidinecarboxamide, 2-(butylamino)-4-[(trans-4-hydroxycyclohexyl)amino]-N-[[4-(1H-imidazol-1-yl)phenyl]methyl] |
| 中文别名 |
UNC 2881,MER激酶抑制剂
N-(4-(1H-咪唑-1-基)苄基)-2-(丁胺基)-4-((1R,4R)-4-羟基环己基)氨基)嘧啶-5-甲酰胺 N-(4-(1H-咪唑-1-基)苄基)-2-(丁胺基)-4-((反式-4-羟基环己基)氨基)嘧啶-5-甲酰胺 |
| 英文别名 |
N-(4-(1H-iMidazol-1-yl)benzyl)-2-(butylaMino)-4-(((1r,4r)-4-hydroxycyclohexyl)amino)pyriMidine-5-cboxaMide
UNC 2881,Mer,phosphorylation,inhibit,UNC-2881,orally active,UNC2881,Tyro3,pathologic thrombosis,Axl,Inhibitor,platelet agegation,TAM Rector 2-(Butylamino)-4-[(trans-4-hydroxycyclohexyl)amino]-N-[[4-(1H-imidazol-1-yl)phenyl]methyl]-5-pyrimidinecboxamide 5-Pyrimidinecboxamide, 2-(butylamino)-4-[(trans-4-hydroxycyclohexyl)amino]-N-[[4-(1H-imidazol-1-yl)phenyl]methyl] N-(4-(1H-imidazol-1-yl)benzyl)-2-(butylamino)-4-((1r,4r)-4-hydroxycyclohexylamino)pyrimidine-5-cboxamide UNC2881 UNC 2881; UNC-2881 N-(4-(1H-Imidazol-1-yl)benzyl)-2-(butylamino)-4-(((1r,4r)-4-hydroxycyclohexyl)amino)pyrimidine 2-(Butylamino)-4-[(trans-4-hydroxycyclohexyl)amino]-N-[4-(1H-imidazol-1-yl)benzyl]-5-pyrimidinecarboxamide UNC2881 //BP UNC2881 ,S7325 UNC2881, 10 mM in DMSO N-(4-(1H-Imidazol-1-yl)benzyl)-2-(butylamino)-4-((trans-4-hydroxycyclohexyl)amino)pyrimidine-5-cboxamide UNC2881 2-(Butylamino)-4-[(4-hydroxycyclohexyl)amino]-N-[(4-imidazol-1-ylphenyl)methyl]pyrimidine-5-cboxamide |
| 描述 | UNC2881是特异的Mer激酶抑制剂,能抑制稳态的Mer激酶磷酸化,IC50为22 nM。 |
|---|---|
| 相关类别 | |
| 参考文献 |
| 密度 | 1.3±0.1 g/cm3 |
|---|---|
| 分子式 | C25H33N7O2 |
| 分子量 | 463.575 |
| 精确质量 | 463.269562 |
| PSA | 116.99000 |
| LogP | 3.03 |
| 外观性状 | 粉末 |
| 折射率 | 1.666 |
| 储存条件 | -20℃ |
| 水溶解性 | Insuluble (1.7E-3 g/L) (25 ºC) |
| 符号 |
GHS07 |
|---|---|
| 信号词 | Warning |
| 危害声明 | H302 |
| 警示性声明 | P301 + P312 + P330 |
| 危险品运输编码 | NONH for all modes of transport |